Search Results 861-870 of 16202 for chemoprevention

  1. Target Field Pitch for Prevention: Raising Awareness of Cancers that Can be Defeated - Mayo Clinic News Network

    WHAT: Mayo Clinic, Fight Colorectal Cancer and Ed Randall's Fans for the Cure will encourage baseball fans to “pitch in” to prevent prostate and colorectal ...

  2. Below are current clinical trials. 2790 studies in Mayo Clinic Comprehensive Cancer Center — Research (all studies, either open or closed). Filter this list of ...

  3. Isolating and Testing Circulating Tumor DNA and Soluble Immune Markers During the Course of Treatment for Lung Cancer - Mayo Clinic

    The purpose of this study is to explore the detection of circulating tumor DNA, soluble immune markers, and the evaluation of peripheral blood mononuclear cells ...

  4. Cancer Clinical Trials - Medical Professionals

    This randomized, active controlled, multicenter Phase III open-label study is designed to evaluate the efficacy and safety of alectinib compared with ...

  5. Tolerability, safety and deep response found in cevostamab phase 1 trial - Mayo Clinic

    A midterm analysis of a multisite phase 1 study of cevostamab for relapsed or refractory multiple myeloma (RRMM) finds the drug safe and tolerable with deep ...

  6. A Study of MBG453 in Combination With Azacitidine and Venetoclax in AML Patients Unfit for Chemotherapy - Mayo Clinic

    This trial will seek to extend the preliminary findings of efficacy of MBG453 in combination with hypomethylating agents (HMA) by evaluating MBG453 in ...

  7. Below are current clinical trials. 2790 studies in Mayo Clinic Comprehensive Cancer Center — Research (all studies, either open or closed). Filter this list of ...

  8. Mayo Clinic Comprehensive Cancer Center — Research

    This laboratory study is looking at genetic mutations and environmental exposure in young patients with retinoblastoma and in their parents and young healthy ...

  9. Mayo Clinic Comprehensive Cancer Center — Research

    The purpose of this study is to compare immunotherapy drugs (nivolumab or brentuximab vedotin) when given with combination chemotherapy in treating patients ...

  10. Mayo Clinic Comprehensive Cancer Center — Research

    Success of cancer immunotherapy is limited by the ability of solid tumors to evade local and systemic antitumoral immune responses.